Pricing Log in Create free account
Friday 6 November 2026 Export LFST’s income statement to Excel — free account

LifeStance Health Group, Inc.

LFST Healthcare Medical Care Facilities

LifeStance Health Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 13.9% from fiscal 2024.

Revenue
+25.3%
EPS
+2,042.9%
Free cash flow
+31.6%
Total debt
−5.15%

Quarter to September 2026, against a year earlier

13.44 0.77 −5.42%
Market cap
$5.1B
P/E
70.7×
Fwd P/E
81.1×
Dividend yield
—
F-score
8/9
Altman Z
2.65
Beneish M
−2.96
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

LifeStance Health Group, Inc. (LFST) EV/EBITDA

Alert me on EV/EBITDA

As of 5 November 2026, LifeStance Health Group, Inc. (LFST) trades at a EV/EBITDA of 32.0×. Over the past ten years it has ranged from 0.0× (September 2024) to 2,161× (July 2021); the current reading is higher than 66% of that period. That is above the Medical Care Facilities industry median of 11.9× and above the Healthcare sector median of 8.4×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 34.2× (51.94%)
FY2024 71.2× —
FY2023 0.0× —
FY2022 0.0× —
FY2021 0.0× —
FY2020 148× 0.00%
FY2019 148× —

Quarterly newest first

Period EV/EBITDA Change
Sep 2026 28.7× (7.10%)
Jun 2026 30.9× 22.11%
Mar 2026 25.3× (26.05%)
Dec 2025 34.2× 0.26%
23 more quarters

Against its own ten years

Low 0.0× High 2,161×
Ten-year median 0.0×
Current reading's percentile 66

EV/EBITDA against peers

Company EV/EBITDA
ACHC Acadia Healthcare Company, Inc. compare 9.9×
SGRY Surgery Partners, Inc. compare 11.2×
OPCH Option Care Health, Inc. compare 13.7×
CON Concentra Group Holdings Parent, Inc. compare 14.0×
AVAH Aveanna Healthcare Holdings Inc. compare 14.1×
NHC National HealthCare Corporation compare 16.1×
PACS PACS Group, Inc. compare 16.2×
CHE Chemed Corporation compare 16.3×
LFST LifeStance Health Group, Inc. 32.0×
Medical Care Facilities industry median 11.9×
Healthcare sector median 8.4×
Market median 10.9×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on LFST